Hypoglycemia was unheard of and mostly noticed in people concomitantly obtaining insulin secretagogues or insulin, in keeping with the glucose-dependent mechanism of motion. Significant hypoglycemia was unusual, supporting a good hazard-benefit profile for each diabetic and non-diabetic populations.Ongoing refinement of formulation and dosing appro